News 23 mai 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Actualités 23 nov 2022 La biopharma genevoise ObsEva vend sa licence Ebopiprant pour près de USD 113 millions ObsEva, spécialiste de la santé féminine et reproductive, a annoncé la vente de sa licence pour l’Ebopiprant à la société de biotechnologie calif...
News 10 jan 2024 Noor Biotech opts to establish location in Basel Noor Biotech has established a presence in Basel. The start-up, which is managed by its Saudi Arabian co-founder Nuha Alekhmini, is developing a ...
Actualités 01 fév 2022 Merck rachète la société biopharmaceutique genevoise Chord Therapeutics Chord Therapeutics, société biopharmaceutique de phase clinique qui développe des médicaments pour des maladies neuroinflammatoires rares, est ra...
Analisi 22 mar 2021 Marketing digitale B2B in China Il panorama digitale in Cina è unico e in rapida evoluzione, molto diverso da quello europeo. Per scoprire come se la cavano le aziende svizzere ...
Member of the Month 03 fév 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
Aktuell 23 aoû 2023 HSLU eröffnet mikrobiologisches Analyselabor in Hergiswil Die Hochschule Luzern (HSLU) hat in Hergiswil ein mikrobiologisches Analyselabor eingerichtet. Hier kann interdisziplinär zur Keimbelastung in Lu...
News 13 juil 2021 Merck reaches key milestone in the construction of its Biotech Development Center Merck has celebrated the completion of the structural work on its Biotech Development Center currently under construction in Corsier-sur-Vevey.
News 19 déc 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News 04 déc 2023 Cradle raises 24 million US dollars Cradle has raised 24 million dollars in a Series A funding round. The biotech startup has developed a platform that enables biologists to design ...
Actualités 22 mar 2023 Trois projets genevois innovants remportent un financement du FIF Les start-ups genevoises Plair, Endotelix et Dr. Beat Walpoth ont reçu le Fongit Innovation Fund (FIF) pour leurs remarquables innovations.
News 11 déc 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
Global Opportunities 29 oct 2018 Nanotechnology development and opportunities for Swiss companies in Malaysia Nanotechnology initiatives and development in Malaysia are aligned with a growing global revenue of nano-enabled sectors. The new government seek...
Third Party Event How can Swiss biotech and medtech start-ups and SMEs harness their innovative businesses and take them to the Indian market?
News 12 déc 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
Analysis 22 mar 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
News 30 jan 2023 Alithea Genomics and CHUV to help make immunotherapy treatments more targeted Dutch-Swiss consortium MAINLINE, consisting of PamGene International B.V., Alithea Genomics and CHUV, received a Eurostars grant of EUR 1 million...
News 18 jan 2023 The University of Fribourg unveils bioinspired nanosensors for early detection of cancer Scientists from the University of Fribourg have developed bioinspired nanosensors for rapid, sensitive, and specific detection of cancer-derived ...